Портфель интегративных средств кибербезопасности Hillstone Networks включает перспективные платформы брандмауэров на базе ИИ, поддерживающие все рабочие нагрузки и сценарии развертывания. САНТА-КЛАРА, Калифорния, 21 мая 2024 г. /PRNewswire/ — Компания Hillstone Networks, ведущий…

Findings from the extended LIBERTY studies and associated post-hoc analysis support the long-term efficacy and safety of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab[1],[2] Data from a post-hoc analysis of the LIBERTY-CD study showed that, despite affecting drug…

Two Studies Presented at Digestive Disease Week® (DDW) Highlights How Digital Platform Engages Patients In Between Appointments to Reduce Risk for Complications CHICAGO, May 21, 2024 /PRNewswire/ — SonarMD today presented positive results from two large, longitudinal studies evaluating…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.